Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models.

ABSTRACT: An amendment to this paper has been published and can be accessed via a link at the top of the paper.

SUBMITTER: Kuo CT 

PROVIDER: S-EPMC7434874 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature